Verified June 2016 by University of Electronic Science and Technology of China

Sponsor:

Collaborators:

German Research Foundation

University Hospital, Bonn

Information provided by (Responsible Party):

Benjamin Becker, University of Electronic Science and Technology of China

ClinicalTrials.gov Identifier:

NCT02801422

First received: June 11, 2016

Last updated: June 11, 2016

Last verified: June 2016

The aim of this fMRI study is to investigate neural indices of relapse in cannabis dependence. The development and maintenance of drug addictions have been associated with deficits in cognitive control, craving and impaired stress regulation. Therefore, neural markers of brain processes underlying the beforementioned components will be studied. Subsequent follow-up drug use interviews will reveal associations between relapse in cannabis dependence and alterations in brain networks of cognitive control, craving and stress.

Cannabis Dependence Other: fMRI

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Altered Neural Activation Patterns of Emotional Processing in Dependent Cannabis Users Associated With Relapse

Primary Outcome Measures:

  • fMRI neural activation patterns of emotional processing [ Time Frame: one time point = fMRI assessment after minimum 24 hours of abstinence ] [ Designated as safety issue: No ]

    Activation patterns associated with emotion processing, emotion regulation, craving and stress are determined in addicted cannabis users compared to non-using matched control subjects

Secondary Outcome Measures:

Estimated Enrollment: 75
Study Start Date: February 2016
Estimated Study Completion Date: February 2018
Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)
Cannabis Dependence

ages 18-40

Other: fMRI
Healthy control subjects

socio-demographically matched

Other: fMRI

Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Cannabis dependent individuals

Inclusion Criteria:

  • Cannabis Dependence
  • 24 hours abstinence

Exclusion Criteria:

  • other DSM-4 diagnosis
  • neurological disorder

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02801422

University of Bonn
Bonn, North Rhine Westfalia, Germany, 53127
Contact: Benjamin Becker, PhD    +4917620090499    ben_becker@nullgmx.de   
Contact: Kaeli Zimmermann, MSc    +4922828719704    kaeli.zimmermann@nullgmx.de   

University of Electronic Science and Technology of China

German Research Foundation

University Hospital, Bonn

Responsible Party: Benjamin Becker, Prof. Dr. rer. nat. Benjamin Becker, University of Electronic Science and Technology of China
ClinicalTrials.gov Identifier: NCT02801422     History of Changes
Other Study ID Numbers: ART_Can_03 
Study First Received: June 11, 2016
Last Updated: June 11, 2016
Health Authority: Germany: Ethics Board University Bonn

Keywords provided by University of Electronic Science and Technology of China:

cannabis
fMRI
addiction
relapse

Additional relevant MeSH terms:

Recurrence
Marijuana Abuse
Disease Attributes
Pathologic Processes
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 25, 2016